Uncategorized

FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period – STAT

Posted on Author Comments Off on FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period – STAT
  1. FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period  STAT
  2. FDA says tirzepatide shortage is over after taking a second look  NBC News
  3. FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage  CNBC
  4. FDA finalizes decision to end Lilly’s GLP-1 shortage, analysts predict Novo will be next  Yahoo Finance
  5. Zepbound, Mounjaro shortages are resolved, FDA confirms  BioPharma Dive